Skip to main content
. 2008 Apr 18;466(6):1285–1291. doi: 10.1007/s11999-008-0243-2

Fig. 1.

Fig. 1

A single oral dose of SalpIL2 decreased pulmonary tumor volume by 78% with respect to saline controls (17.07 and 79.76 mm3 respectively; p < 0.0037). Sal-NG tended (p = 0.25) to reduce pulmonary metastatic tumor volume 50% from a mean of 80.0 in control animals to 39.8 mm3. * Indicates statistically significance.